{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:32:20Z","timestamp":1761823940328,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["neuromodulationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromodulation: Technology at the Neural Interface"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1111\/ner.12745","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T10:47:59Z","timestamp":1513680479000},"page":"805-808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Does Psychological Disturbance Predict Explantation in Successful Pelvic Neuromodulation Treatment for Bladder Dysfunction? A Short Series"],"prefix":"10.1016","volume":"21","author":[{"given":"Tariq F.","family":"Al-Shaiji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam A.","family":"Malallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said M.","family":"Yaiesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullatif E.","family":"Al-Terki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdy M.","family":"Hassouna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/ner.12745_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00345-011-0780-2","article-title":"Sacral neuromodulation for lower urinary tract dysfunction","volume":"30","author":"Van Kerrebroeck","year":"2012","journal-title":"World J Urol"},{"key":"10.1111\/ner.12745_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1464-410X.2003.04105.x","article-title":"The role of neuromodulation in the management of urinary urge incontinence","volume":"91","author":"Abrams","year":"2003","journal-title":"BJU Int"},{"key":"10.1111\/ner.12745_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-5347(17)42297-X","article-title":"Clinical significance of sacral and pudendal nerve anatomy","volume":"139","author":"Juenemann","year":"1988","journal-title":"J Urol"},{"key":"10.1111\/ner.12745_bib4","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1097\/00005392-199805000-00017","article-title":"Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention","volume":"159","author":"Shaker","year":"1998","journal-title":"J Urol"},{"unstructured":"Medtronic. About Medtronic Bladder Control Therapy. Medtronic; c2016. http:\/\/www.medtronic.com\/patients\/overactive-bladder\/about-therapy\/questions-answers\/index.htm","key":"10.1111\/ner.12745_bib5"},{"key":"10.1111\/ner.12745_bib6","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.juro.2007.07.032","article-title":"Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study","volume":"178","author":"Van Kerrebroeck","year":"2007","journal-title":"J Urol"},{"key":"10.1111\/ner.12745_bib7","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0022-5347(05)67728-2","article-title":"Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of a prospective longitudinal study","volume":"163","author":"Bosch","year":"2000","journal-title":"J Urol"},{"key":"10.1111\/ner.12745_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s001920070031","article-title":"Patient satisfaction and complications following sacral nerve stimulation for urinary retention, urge incontinence and perineal pain: a multicenter evaluation","volume":"11","author":"Everaert","year":"2000","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1111\/ner.12745_bib9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0090-4295(02)01841-1","article-title":"Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction","volume":"60","author":"Scheepens","year":"2002","journal-title":"Urology"},{"key":"10.1111\/ner.12745_bib10","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0022-5347(17)32311-X","article-title":"Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients","volume":"152","author":"Koldewijn","year":"1994","journal-title":"J Urol"},{"key":"10.1111\/ner.12745_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1464-410X.2012.10906.x","article-title":"Surgery illustrated - surgical atlas sacral neuromodulation","volume":"110","author":"W\u00f6llner","year":"2012","journal-title":"BJU Int"},{"unstructured":"European Association of Urology Guidelines. EAU Guidelines on urinary incontinence. European Association of Urology. http:\/\/uroweb.org\/wp-content\/uploads\/20-Urinary-Incontinence_LR1.pdf","key":"10.1111\/ner.12745_bib12"},{"key":"10.1111\/ner.12745_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nau.20870","article-title":"Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence","volume":"29","author":"Abrams","year":"2010","journal-title":"Neurourol Urodyn"},{"unstructured":"The National Institute for Health and Care Excellence (NICE) Guidance. Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention. The National Institute for Health and Care Excellence. http:\/\/www.nice.org.uk\/guidance\/ipg536","key":"10.1111\/ner.12745_bib14"},{"unstructured":"Gormley EA, Lightner DJ, Burgio KL et al. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA\/SUFU Guideline. AUA\/SUFU. http:\/\/www.auanet.org\/common\/pdf\/education\/clinical-guidance\/Overactive-Bladder.pdf","key":"10.1111\/ner.12745_bib15"},{"key":"10.1111\/ner.12745_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0090-4295(00)00597-5","article-title":"Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention","volume":"56","author":"Siegel","year":"2000","journal-title":"Urology"},{"key":"10.1111\/ner.12745_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/nau.20786","article-title":"Efficacy and adverse events of sacral nerve stimulation for overactive bladder: a systematic review","volume":"29","author":"Siddiqui","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/ner.12745_bib18","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1464-410X.2011.10205.x","article-title":"Psychological and psychiatric factors as predictors for success in sacral neuromodulation treatment","volume":"108","author":"Marcelissen","year":"2011","journal-title":"BJU Int"},{"key":"10.1111\/ner.12745_bib19","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1007\/DCR.0b013e3181b55595","article-title":"Factors associated with percutaneous nerve evaluation and permanent sacral nerve modulation outcome in patients with fecal incontinence","volume":"52","author":"Govaert","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1111\/ner.12745_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10350-006-0746-4","article-title":"Sacral nerve stimulation in fecal incontinence: are there factors associated with success?","volume":"50","author":"Gourcerol","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"10.1111\/ner.12745_bib21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.urology.2005.04.031","article-title":"Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure?","volume":"66","author":"Amundsen","year":"2005","journal-title":"Urology"},{"key":"10.1111\/ner.12745_bib22","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.ajog.2005.07.038","article-title":"Sacral neuromodulation for the treatment of refractory urinary urge incontinence after stress incontinence surgery","volume":"193","author":"Sherman","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/ner.12745_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nau.20330","article-title":"In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction","volume":"26","author":"Foster","year":"2007","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/ner.12745_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s003450050074","article-title":"Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes","volume":"16","author":"Weil","year":"1998","journal-title":"World J Urol"},{"key":"10.1111\/ner.12745_bib25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.urology.2008.11.047","article-title":"Incidence and predictors of complications with sacral neuromodulation","volume":"73","author":"White","year":"2009","journal-title":"Urology"},{"key":"10.1111\/ner.12745_bib26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00192-011-1512-2","article-title":"Determining outcomes, adverse events, and predictors of success after sacral neuromodulation for lower urinary disorders in women","volume":"22","author":"Yazdany","year":"2011","journal-title":"Int Urogynecol J"},{"key":"10.1111\/ner.12745_bib27","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.160.14.2101","article-title":"Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence","volume":"160","author":"DiMatteo","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1111\/ner.12745_bib28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/SPV.0000000000000062","article-title":"Psychosocial factors related to the use of InterStim(R) for the treatment of refractory overactive bladder","volume":"20","author":"Levin","year":"2014","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1111\/ner.12745_bib29","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/nau.22871","article-title":"Screening for depression and anxiety in patients with storage or voiding dysfunction: a retrospective cohort study predicting outcome of sacral neuromodulation","volume":"35","author":"Drossaerts","year":"2016","journal-title":"Neurourol Urodyn"}],"container-title":["Neuromodulation: Technology at the Neural Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fner.12745","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715921018377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715921018377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ner.12745\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:56:37Z","timestamp":1761083797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094715921018377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1094715921018377"],"URL":"https:\/\/doi.org\/10.1111\/ner.12745","relation":{},"ISSN":["1094-7159"],"issn-type":[{"type":"print","value":"1094-7159"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Psychological Disturbance Predict Explantation in Successful Pelvic Neuromodulation Treatment for Bladder Dysfunction? A Short Series","name":"articletitle","label":"Article Title"},{"value":"Neuromodulation: Technology at the Neural Interface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ner.12745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}